Exozymes sets Nov. 13, 2026 shareholder meeting

EXOZYMES INC. set the date, record date and expected mailing date for its 2026 annual shareholder meeting.

Rhea-AI Filing Summary

EXOZYMES INC. (EXOZ) announced key details for its 2026 annual meeting of shareholders. The company plans to hold the annual meeting on November 13, 2026.

Shareholders of record as of September 15, 2026 will be entitled to vote, and the company plans to distribute its proxy statement and proxy around September 28, 2026.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

2026 annual meeting date: November 13, 2026 Record date: September 15, 2026 Planned proxy mailing date: On or about September 28, 2026 +2 more

5 metrics

2026 annual meeting date November 13, 2026 Scheduled date for EXOZYMES INC. annual meeting of shareholders

Record date September 15, 2026 Shareholders of record on this date may vote at the 2026 annual meeting

Planned proxy mailing date On or about September 28, 2026 Planned distribution timing for proxy statement and proxy materials

Trading symbol EXOZ Ticker for EXOZYMES INC. common stock

Exchange listing Nasdaq Capital Market Market where EXOZ common stock is listed

Key Terms

record date, proxy statement, Nasdaq Capital Market

3 terms

record date financial

"The record date for the meeting was September 15, 2026"

The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.

proxy statement regulatory

"plans to distribute its proxy statement and proxy to the shareholders"

A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.

Nasdaq Capital Market market

"Common Stock | EXOZ | The Nasdaq Stock Market LLC (Nasdaq Capital Market)"

The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will EXOZYMES INC. (EXOZ) hold its 2026 annual meeting?

EXOZYMES INC. plans to hold its 2026 annual meeting on November 13, 2026. The company disclosed this timing under an Other Events item related to annual meeting arrangements.

What is the record date for EXOZYMES INC. (EXOZ) 2026 annual meeting?

The record date for EXOZYMES INC.’s 2026 annual meeting is September 15, 2026. Shareholders of record on that date will be entitled to receive the proxy materials and vote at the meeting.

When will EXOZYMES INC. (EXOZ) mail its 2026 proxy statement and proxy?

EXOZYMES INC. plans to distribute its proxy statement and proxy to shareholders on or about September 28, 2026. These materials will provide details on meeting matters and voting procedures.

Where is EXOZYMES INC. (EXOZ) headquartered according to this filing?

EXOZYMES INC. lists its principal executive offices at 750 Royal Oaks Drive, Suite 106, Monrovia, CA 91016, and provides a main telephone number of (626) 415-1488.

On which exchange is EXOZYMES INC. (EXOZ) common stock listed?

EXOZYMES INC.’s common stock, trading under the symbol EXOZ, is listed on The Nasdaq Stock Market LLC (Nasdaq Capital Market).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/18/2026 - 01:25 PM Accepted by SEC EDGAR 09/18/2026 - 01:24 PM Learn about SEC filing dates

false 0002010788 0002010788 2026-09-17 2026-09-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 17, 2026

EXOZYMES INC.

(Exact name of registrant as specified in its charter)

Nevada		001-42204		83-4550057
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

750 Royal Oaks Drive, Suite 106

Monrovia, CA 91016

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (626) 415-1488

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock		EXOZ		The Nasdaq Stock Market LLC (Nasdaq Capital Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company: ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

The Company determined to hold its 2026 annual meeting on November 13, 2026, and plans to distribute its proxy statement and proxy to the shareholders on or about September 28, 2026. The record date for the meeting was September 15, 2026.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Name of Exhibit
104*		Cover Page Interactive Data File (embedded within the inline XBRL document).

* Filed or furnished herewith

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	EXOZYMES INC.
	By:	/s/ Fouad Nawaz
	Name:	Fouad Nawaz,
	Title:	Vice President, Finance

Dated: September 18, 2026

3

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 2.9 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB